Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy
NCT02381444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136
Last updated 2020-12-09
Summary
The aim of this study is to assess the effect of LCIG (levodopa-carbidopa intestinal gel) on HRQL (Health-Related Quality of Life) of participants and compare the Health-Related Quality of Life between participants continuing to levodopa-carbidopa intestinal gel treatments versus participants continuing on oral therapy for Parkinson's Disease.
Conditions
- Parkinson's Disease (PD)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AbbVie Inc. · AbbVie
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-17
- Primary Completion
- 2020-01-07
- Completion
- 2020-01-07
Countries
- Germany
- Switzerland
Study Locations
More Related Trials
-
Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease
NCT07313176 ·Status: RECRUITING
-
A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)
NCT02799381 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
NCT01484990 ·Status: COMPLETED ·Phase: PHASE1
-
Neuromodulation and Language Acquisition (Project Stage Ia)
NCT00102284 ·Status: TERMINATED ·Phase: PHASE4
-
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
NCT00335153 ·Status: COMPLETED ·Phase: PHASE3
-
eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.
NCT04990284 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
NCT00141518 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
NCT06937034 ·Status: RECRUITING
-
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026 ·Status: COMPLETED ·Phase: PHASE4
-
Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
NCT06432309 ·Status: COMPLETED ·Phase: NA
-
Basal Ganglia Local Field Potentials in Gait and Speech
NCT01905995 ·Status: UNKNOWN
-
Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease
NCT03517059 ·Status: COMPLETED
-
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
NCT06115538 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
NCT07227896 ·Status: NOT_YET_RECRUITING
-
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
NCT00415844 ·Status: COMPLETED ·Phase: PHASE1
-
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
NCT00306124 ·Status: UNKNOWN ·Phase: PHASE4
-
Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment
NCT02509325 ·Status: COMPLETED
-
A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease
NCT02230904 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
NCT00134966 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease
NCT02227355 ·Status: COMPLETED
-
Study of Neurodegenerative Diseases Induced Stem Cells in Patients and Healthy Family Controls.
NCT03682458 ·Status: UNKNOWN
-
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
NCT02615873 ·Status: UNKNOWN ·Phase: PHASE3
-
LIPAD - LRRK2 International Parkinson's Disease Study
NCT04214509 ·Status: UNKNOWN
-
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
NCT00415831 ·Status: COMPLETED ·Phase: PHASE1
-
Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)
NCT02535884 ·Status: COMPLETED ·Phase: NA